Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cigarette smoking combined with genetic variation regulates the m6A methylation of CRNKL1 and is associated with bladder cancer risk.

Environmental toxicology - 1 May 2024

Yang Jialei, Ji Zihan, Gao Fang, Wu Jiajin, Du Mulong, Zhang Zhengdong, Yuan Lin, Zheng Rui, Wang Meilin

Abstract excerpt

Cigarette smoking was known to accelerate the occurrence and development of bladder cancer by regulating RNA modification. However, the association between the combination of cigarette smoking and RNA modification-related single nucleotide polymorphisms (RNAm-SNPs) and bladder cancer risk remains unclear. In this study, 1681 participants, including 580 cases and 1101 controls, were recruited for genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Cigarette Smoking

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Methylation

Share to Nuclear Proteins

Share to Polymorphism, Single Nucleotide

Share to Risk Factors

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 38270278
DOI: 10.1002/tox.24138

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cigarette smoking combined with genetic variation regulates the m6A methylation of CRNKL1 and is associated with bladder cancer risk.PMID 38270278Read ↗

N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder CancerSemantic proximity Read ↗

Integrative machine learning algorithms for developing a consensus RNA modification-based signature for guiding clinical decision-making in bladder cancerSemantic proximity Read ↗

Identification and Validation of N6-methyladenosine-related Biomarkers for Bladder Cancer: Implications for ImmunotherapySemantic proximity Read ↗

RMVar: an updated database of functional variants involved in RNA modifications.Semantic proximity Read ↗

Identification of genetic variants in m6A modification genes associated with pancreatic cancer risk in the Chinese population.Semantic proximity Read ↗

Genetic variants in N6-methyladenosine are associated with bladder cancer risk in the Chinese population.Semantic proximity Read ↗

Kdm6a Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with p53 DysfunctionSemantic proximity Read ↗

RMDisease: a database of genetic variants that affect RNA modifications, with implications for epitranscriptome pathogenesis.Semantic proximity Read ↗

An integrative approach for identification of smoking-related genes involving bladder cancer.Semantic proximity Read ↗

AKR1C2 genetic variants mediate tobacco carcinogens metabolism involving bladder cancer susceptibility.Semantic proximity Read ↗

Loss of KDM6A-mediated genomic instability and metabolic reprogramming regulates response to therapeutic perturbations in bladder cancer.Semantic proximity Read ↗

RMVar 2.0: an updated database of functional variants in RNA modifications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.